Cargando…
Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease
Stevens–Johnson syndrome (SJS) is a severe mucocutaneous adverse drug reaction with a relatively high mortality rate. SJS is described during herpes simplex virus type 1 (HSV1) infection and, rarely, even during adalimumab therapy. We report the case of a patient with Crohn's disease who develo...
Autores principales: | Roselli, Jenny, Innocenti, Tommaso, Lynch, Erica Nicola, Parisio, Laura, Apolito, Pasquale, Mello, Tommaso, Macrì, Giuseppe, Milla, Monica, Biagini, Maria Rosa, Tarocchi, Mirko, Milani, Stefano, Galli, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180430/ https://www.ncbi.nlm.nih.gov/pubmed/32351742 http://dx.doi.org/10.1155/2020/3875024 |
Ejemplares similares
-
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease
por: Roselli, Jenny, et al.
Publicado: (2020) -
Fulminant Herpes Simplex Hepatitis Secondary to Adalimumab in Crohn’s
Disease: A Case Report
por: Goel, Kanika, et al.
Publicado: (2019) -
Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016) -
"Síndrome de Stevens-Johnson"
por: Mortera Carbonell, María de los Angeles
Publicado: (1992) -
Stevens Johnson Syndrome – “Steven Who? And Why I Should Care About His Johnson?”
por: Cardon, Zachary E., et al.
Publicado: (2019)